TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,275,000 | +175.1% | 30,235 | -1.8% | 0.01% | +250.0% |
| Q1 2022 | $827,000 | -45.6% | 30,789 | -3.4% | 0.00% | -50.0% |
| Q4 2021 | $1,520,000 | -34.0% | 31,861 | -8.1% | 0.00% | -33.3% |
| Q3 2021 | $2,303,000 | -15.9% | 34,672 | -1.2% | 0.01% | -14.3% |
| Q2 2021 | $2,738,000 | -23.0% | 35,091 | -6.6% | 0.01% | -30.0% |
| Q1 2021 | $3,554,000 | -19.6% | 37,570 | +3.6% | 0.01% | -16.7% |
| Q4 2020 | $4,420,000 | +37.6% | 36,271 | -1.4% | 0.01% | +20.0% |
| Q3 2020 | $3,212,000 | +31.6% | 36,768 | -2.7% | 0.01% | +25.0% |
| Q2 2020 | $2,441,000 | +39.6% | 37,804 | -3.4% | 0.01% | +14.3% |
| Q1 2020 | $1,748,000 | -30.7% | 39,146 | -3.4% | 0.01% | -12.5% |
| Q4 2019 | $2,523,000 | – | 40,506 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |